http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106748939-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C337-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C337-08
filingDate 2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106748939-B
titleOfInvention A kind of novel bromine phenol thiosemicarbazide compound and its preparation and drug and purposes
abstract The present invention relates to the preparation of a kind of bromine phenol thiosemicarbazide compound I-IV and the combinations and application of such compound, and the invention further relates to the preparation method of such compound, the chemical structure of general formula of the compound is as follows: R in general structure 1 、R 2 、R 3 、R 4 、R 5 And R 6 For H, Br, OH, OCH 3 One or both of, R in compound I 1 And R 2 For Br, R 3 And R 4 For OCH 3 , R 5 And R 6 For H;R in compound II 1 、R 2 And R 5 For Br, R 3 And R 4 For OCH 3 , R 6 For H;R in compound III 1 And R 2 For Br, R 3 And R 4 For OH, R 5 For H, R 6 For phenyl;R in compound IV 1 And R 2 For Br, R 3 And R 4 For OH, R 5 And R 6 For H;The invention further relates to contain at least one above compound or its salt formed with physiologically acceptable inorganic acid or organic acid;The invention further relates to the above formula compound form of administration containing at least one structural formula compound or its salt, dosage form is tablet, capsule, infusion solution, suppository, patch, pulvis, suspension etc..
priorityDate 2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5370664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449910618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420645183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2781094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416344866
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID99490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66602496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71699274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410444215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416192495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11045555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID99490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420619752

Total number of triples: 43.